// App-Quantinova.ai

321 : A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates

Researchers

Presenter

  • Paul D Miller

Principal Investigators

  • N Pannacciulli

  • J Malouf

  • A Singer

  • E Czerwinski

  • HG Bone

  • C Wang

  • Rachel B. Wagman

Medical Centers

  • JP Brown

  • Colorado Center for Bone Research, Lakewood, CO

  • Amgen Inc, Thousand Oaks, CA

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Georgetown University Medical Center, Washington, DC

  • Krakow Medical Center, Krakow, Poland

  • Michigan Bone and Mineral Clinic, Detroit, MI

  • CHU de Quebec and Laval University, Quebec, QC, Canada

Locations

  • United States

  • Spain

  • Poland

  • Canada

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Zoledronic acid

  • Alendronate sodium

  • Ibandronic acid

  • Risedronate sodium

  • Denosumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved